NumFin

Galaxy Biomedical Investment Co., Ltd.

Symbol: 000806.SZ

SHZ

1

CNY

company-market-status

  • -3.4043

    P/E ratio

  • 0.0019

    PEG ratio

  • 1.10B

    Mrk Cap

  • 0.00%

    Div Yield

Акции в обращение

1099.910016M

Притежавани от вътрешни лица

0.000%

Притежавани от институции

0.000%

  • Highest
    • 5.29
    • 3.98
    • 3.94
    • 3.12
    • 4.85
    • 6.07
    • 2.48
    • 2.08
    • 2.07
    • 1.70
    • 1.39
    • 1.72
    • 1.64
    • 1.69
    • 1.78
    • 1.74
    • 2.41
    • 2.52
    • 3.57
    • 2.56
    • 2.46
    • 2.61
    • 2.52
    • 2.14
    • 2.07
    • 2.35
    • 2.33
    • 2.25
    • 2.11
    • 2.24
    • 1.79
    • 1.63
  • Lowest
    • 5.14
    • 3.87
    • 3.83
    • 2.93
    • 4.37
    • 6.07
    • 2.42
    • 2.02
    • 2.00
    • 1.65
    • 1.26
    • 1.66
    • 1.60
    • 1.66
    • 1.65
    • 1.66
    • 2.27
    • 2.44
    • 3.34
    • 2.45
    • 2.39
    • 2.56
    • 2.40
    • 2.14
    • 2.02
    • 2.15
    • 2.21
    • 2.16
    • 2.06
    • 2.19
    • 1.79
    • 1.58

Информация за компанията

Последващ PE: Technology
Индустрия: Electronic Components
ГЛАВЕН ИЗПЪЛНИТЕЛЕН ДИРЕКТОР:Mr. Keyang Liu
Служители на пълно работно време:1991
Град:Beihai
Адрес:Yinhe Software Technology Park
IPO:1998-04-16
CIK:
Уебсайт:https://www.g-biomed.com

Galaxy Biomedical Investment Co., Ltd. operates in the transmission and distribution, electronic information, and bio-pharmaceutical industries in China. The company produces and sells various transformer products, such as power, rectifier, and special transformers for use in metal smelting, electrochemistry, and power grid companies; and manufactures and sells electronic components, including displacement sensors, brake resistance boxes, radio frequency components, resistors, potentiometers, and others for use in aviation, aerospace, weapons, ships, AI intelligence, new energy, rail transit, communications, smart grids, instrumentation and other fields. It also offers animal products, and monoclonal antibody and targeted drugs, as well as drugs for the treatment of cancer and other diseases; laboratory equipment; and CRO, CAR-T technology and stem cell technology research and development, malignant cancer immune cell technology, and genetic testing services. The company also exports its products. The company was formerly known as Beihai Yinhe Industry Investment Co., Ltd. and changed its name to Galaxy Biomedical Investment Co., Ltd. in October 2015. Galaxy Biomedical Investment Co., Ltd. was founded in 1993 and is headquartered in Beihai, China.

Оборотен капитал

202220212020201920182017
Парични средства и инвестиции78.0184.58110.00100.4450.75265.88
Приемници0.000.000.000.000.000.00
Инвентарна книга199.62280.50233.44259.52230.22482.69
Други4.697.975.558.761435.111364.69
Общо текущи активи1462.831132.431519.931064.781716.082113.27
Acc Payable285.36261.00304.09339.79265.75295.21
Краткосрочен дълг189.20109.2699.44122.25530.50229.00
Други текущи пасиви569.05430.78735.56753.55228.81192.30
Текущи пасиви1043.61801.031139.091215.591036.53737.38

Капиталова структура

Всички числа в милиони

Общо активи

2182,18 щ.д.

Общо задължения

1088189479,93 щ.д.

Дългосрочен дълг

117,06 щ.д.

Парични средства и екви

568632428,17 щ.д.

Goodwill

0,00 щ.д.

Неразпределена печалба

133192966,07 щ.д.

Обикновени акции

1099,91 щ.д.

Стойност на предприятието

5,82 щ.д.

Дивиденти за маса

ГодиниQ1Q2Q3Q4Общо
19990.0000.0000.0070.0000.007
20000.0000.0180.0000.0000.018
20010.0000.0310.0150.0000.046
20020.0000.0120.0000.0000.012
20040.0000.0180.0000.0000.018
Подобни запаси
Може да се интересувате и от
TEL
TE Connectivity Ltd..
122.48 USD
NYSE
KOPN
Kopin Corporation.
2.17 USD
NASDAQ
PLXS
Plexus Corp..
90.68 USD
NASDAQ
NEON
Neonode Inc..
8.12 USD
NASDAQ
LYTS
LSI Industries Inc..
11.63 USD
NASDAQ
ELTK
Eltek Ltd..
9.92 USD
NASDAQ
NSYS
Nortech Systems Incorporated.
9.6599 USD
NASDAQ
8240.TWO
Wah Hong Industrial Corp..
31.2 TWD
TWO
SANM
Sanmina Corporation.
53.04 USD
NASDAQ
8113.HK
Hi-Level Technology Holdings Limited.
0.188 HKD
HKSE
KIT.OL
Kitron ASA.
45.6 NOK
OSE

Frequently Asked Question

Why is your stock tool better than competitors?

Numfin provides most features for free and gives you accurate and expert data about public companies. We also offer unique features like AI copilot that are not found on other platforms

Can I trust the data on your website and where do they come from?

Absolutely. We receive the data from our partners and other official sources, such as popular stock exchanges (NASDAQ, NYSE, and others), SEC.gov, and other official platforms. Our data provider, FinancialModeling, also provides information for portals like Moody's, Harvard, Chevron, and others. All this proves the accuracy and authority of the information.

Who creates the content on your website and is it approved by experts in finance and investing?

All financial data is received from our data provider and then verified by industry experts. Additionally, we use various AI tools like ChatGPT to present content in a user-friendly and well-structured manner.

What problem does your tool solve? Who is the target audience for your tool

Our main goal is to present accurate and expert information about public companies in a structured manner. We work with investors and financial professionals who have a long-term outlook. Our community consists of private investors, business owners, stock analysts, fund managers, and people who are interested in investing.

Why did you decide to create your tool?

While managing our own money, we searched for the best analytical tool to help us better analyze public companies. Most websites that provided analytics for professional investors were expensive, and the cheap tools were either limited in functionality or lacked valuable company data. Even worse, some of them presented incorrect numbers. As a result, we combined our experience in business, IT, and finance to create the most affordable and useful solution for investors and anyone interested in finance and stock analysis.

What is the difference between free and paid options? Should I buy Pro version from start or it's ok to have a free version?

Most features on our website are free so that many people can use it to analyze companies on the world's top stock exchanges. However, some features, such as our artificial intelligence chat, advanced analytics, filters, and storing of vast historical data, require additional servers from our end. Therefore, we rely on your support to keep this amazing project running. If you would like to experience the full potential of our service, we strongly recommend that you purchase the PRO version, which comes with a 30-day money-back guarantee

Who is your team and do they have enough experience?

You can read about our team here, or you can contact us at [email protected] for more information.